-LCB-_-LRB-
Hormonal_JJ
metabolic_JJ
status_NN
in_IN
breast_NN
cancer_NN
patients_NNS
after_IN
conservative_JJ
surgery_NN
:_:
comparison_NN
with_IN
known_JJ
prognostic_JJ
criteria_NNS
-RCB-_-RRB-

Body_NN
weight_NN
,_,
body_NN
mass_NN
index_NN
,_,
body_NN
fat_NN
,_,
lean_JJ
body_NN
mass_NN
,_,
blood-glucose_NN
,_,
cholesterol_NN
,_,
HDL-cholesterol_NN
,_,
triglyceride_NN
,_,
beta-lipoproteins_NNS
,_,
insulin_NN
,_,
gonadotropin_NN
,_,
estradiol_NN
,_,
testosterone_NN
,_,
SHBG_NN
,_,
T3_NN
,_,
T4_NN
and_CC
TSH_NN
levels_NNS
as_RB
well_RB
as_IN
estradiol_NN
and_CC
progesterone_NN
receptor_NN
levels_NNS
in_IN
excised_VBN
tumor_NN
were_VBD
studied_VBN
in_IN
40_CD
patients_NNS
with_IN
breast_NN
cancer_NN
prior_JJ
to_TO
conservative_JJ
treatment_NN
._.

Said_NN
anthropometric_NN
,_,
metabolic_JJ
and_CC
hormonal_JJ
parameters_NNS
were_VBD
compared_VBN
with_IN
the_DT
index_NN
of_IN
lymphocytic_JJ
infiltration_NN
of_IN
tumor_NN
selected_VBN
as_IN
a_DT
prognostic_JJ
factor_NN
._.

A_DT
significant_JJ
correlation_NN
between_IN
high_JJ
lymphocytic_JJ
infiltration_NN
-LRB-_-LRB-
2.5_CD
points_NNS
-RRB-_-RRB-
,_,
low_JJ
body_NN
mass_NN
and_CC
fat_NN
was_VBD
identified_VBN
._.

Also_RB
,_,
smoking_NN
contributed_VBD
to_TO
loss_NN
of_IN
body_NN
mass_NN
and_CC
fat_NN
;_:
however_RB
,_,
it_PRP
caused_VBD
lymphocytic_JJ
infiltration_NN
to_TO
rise_NN
._.

Moderate_JJ
body_NN
mass_NN
,_,
relatively_RB
low_JJ
fat_NN
level_NN
and_CC
positive_JJ
receptor_NN
status_NN
are_VBP
among_IN
factors_NNS
of_IN
good_JJ
prognosis_NN
in_IN
breast_NN
cancer_NN
of_IN
early_JJ
stages_NNS
._.

